Ontology highlight
ABSTRACT: Rationale & objective
Evidence from clinical trials to guide patient preparation for maintenance dialysis therapy is limited. Although anemia is associated with mortality and cardiovascular (CV) disease in individuals initiating maintenance dialysis therapy, it is not known if treatment of anemia before dialysis therapy initiation with erythropoiesis-stimulating agents alters outcomes.Study design
Post hoc analysis of a randomized controlled trial.Setting & participants
Participants with type 2 diabetes and chronic kidney disease who progressed to dialysis therapy (n=590) in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).Exposure
Randomized treatment assignment (darbepoetin vs placebo).Outcomes
All-cause mortality, CV mortalit
SUBMITTER: Mc Causland FR
PROVIDER: S-EPMC6420804 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature